CHRONIC MYELOMONOCYTIC LEUKAEMIA side effect
What is CHRONIC MYELOMONOCYTIC LEUKAEMIA ?Drugs associated with CHRONIC MYELOMONOCYTIC LEUKAEMIA
ACTOS ALTACE FLUDARA FLUDARABINE HUMIRA NEULASTA PREDNISONE SEROQUEL VEPESIDCHRONIC MYELOMONOCYTIC LEUKAEMIA : Actos Side Effects Report #5642291-5
Consumer or non-health professional from GERMANY reported ACTOS problem on Feb 11, 2008. Female patient, 70 years of age, was diagnosed with type 2 diabetes mellitus and was treated with ACTOS. After drug was administered, patient experienced the following problems/side effects: chronic myelomonocytic leukaemia, disease recurrence, dyspnoea, herpes zoster, necrosis, oedema peripheral, right ventricular failure, scleritis, spinal fracture, . ACTOS dosage: 15 MG (15 MG, 1 IN 1 D) PER ORAL. During the same period patient was treated with VERAPAMIL, CANDESARTAN CILEXETIL, HYDROCHLOROTHIAZIDE, ACETYLSALICYLIC ACID SRT, CALCIUM, VITAMIN D. Patient was hospitalized. Patient recovered.
CHRONIC MYELOMONOCYTIC LEUKAEMIA : Seroquel Side Effects Report #5588258-7
SEROQUEL problem was reported by a Health Professional from ITALY on Jan 07, 2008. Female patient was diagnosed with dementia alzheimer's type and was treated with SEROQUEL. After drug was administered, patient experienced the following problems/side effects: chronic myelomonocytic leukaemia, jaundice cholestatic, . SEROQUEL dosage: unknown. During the same period patient was treated with RIVOTRIL. Patient died on 12/03/2007.
CHRONIC MYELOMONOCYTIC LEUKAEMIA : Seroquel Side Effects Report #5573770-7
Health Professional from ITALY reported SEROQUEL problem on Dec 21, 2007. Female patient was diagnosed with dementia alzheimer's type and was treated with SEROQUEL. After drug was administered, patient experienced the following problems/side effects: chronic myelomonocytic leukaemia, jaundice cholestatic, . SEROQUEL dosage: unknown. During the same period patient was treated with RIVOTRIL. Patient died on 12/03/2007.
CHRONIC MYELOMONOCYTIC LEUKAEMIA : Vepesid Side Effects Report #5506108-1
VEPESID problem was reported by a Physician from JAPAN on Oct 31, 2007. Male patient, 58 years of age, was treated with VEPESID. After drug was administered, patient experienced the following problems/side effects: chronic myelomonocytic leukaemia, . VEPESID dosage: unknown. During the same period patient was treated with NOVANTRONE, DAUNOMYCIN, ACLACINON. Patient recovered.
CHRONIC MYELOMONOCYTIC LEUKAEMIA : Humira Side Effects Report #5520793-X
Physician from UNITED STATES reported HUMIRA problem on Nov 14, 2007. Female patient, weighting 200.2 lb, was diagnosed with rheumatoid arthritis, prophylaxis against gastrointestinal ulcer, hypertension and was treated with HUMIRA. After drug was administered, patient experienced the following problems/side effects: chronic myelomonocytic leukaemia, leukocytosis, neutrophilia, trisomy 8, . HUMIRA dosage: unknown. During the same period patient was treated with OMEPRAZOLE, VALSARTAN, PREDNISONE, HYDROCODONE BITARTRATE, FOLIC ACID, METHOTREXATE. Patient was hospitalized. Patient recovered.
CHRONIC MYELOMONOCYTIC LEUKAEMIA : Fludarabine Side Effects Report #5521162-9
FLUDARABINE PHOSPHATE problem was reported by a Physician from UNITED KINGDOM on Nov 15, 2007. Female patient, 64 years of age, weighting 172.0 lb, was treated with FLUDARABINE PHOSPHATE. After drug was administered, patient experienced the following problems/side effects: chronic myelomonocytic leukaemia, neutropenia, . FLUDARABINE PHOSPHATE dosage: 25 MG/M2, UNK. During the same period patient was treated with FLUDARABINE PHOSPHATE, FLUDARABINE PHOSPHATE, CYCLOPHOSPHAMIDE, CONTRIMOXAZOLE, ALLOPURINOL, ACYCLOVIR. Patient recovered.
CHRONIC MYELOMONOCYTIC LEUKAEMIA : Altace Side Effects Report #5378513-8
Physician from FRANCE reported ALTACE problem on June 25, 2007. Female patient was diagnosed with hypertension and was treated with ALTACE. After drug was administered, patient experienced the following problems/side effects: chronic myelomonocytic leukaemia, sideroblastic anaemia, . ALTACE dosage: 2.5 MG, QD. During the same period patient was treated with SINTROM, LIPANOR, DIGOXIN, AMLODIPINE, JOSIR. Patient was hospitalized. Patient recovered.
CHRONIC MYELOMONOCYTIC LEUKAEMIA : Prednisone Side Effects Report #5393123-4
PREDNISONE problem was reported by a Health Professional from UNITED STATES on July 12, 2007. Female patient, 59 years of age, was treated with PREDNISONE. After drug was administered, patient experienced the following problems/side effects: chronic myelomonocytic leukaemia, cytogenetic abnormality, . PREDNISONE dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE. Patient recovered.
CHRONIC MYELOMONOCYTIC LEUKAEMIA : Altace Side Effects Report #5378513-8
Physician from FRANCE reported ALTACE problem on June 25, 2007. Female patient was diagnosed with hypertension and was treated with ALTACE. After drug was administered, patient experienced the following problems/side effects: chronic myelomonocytic leukaemia, sideroblastic anaemia, . ALTACE dosage: 2.5 MG, QD. During the same period patient was treated with SINTROM, LIPANOR, DIGOXIN, AMLODIPINE, JOSIR. Patient was hospitalized. Patient recovered.
CHRONIC MYELOMONOCYTIC LEUKAEMIA : Prednisone Side Effects Report #5393123-4
PREDNISONE problem was reported by a Health Professional from UNITED STATES on July 12, 2007. Female patient, 59 years of age, was treated with PREDNISONE. After drug was administered, patient experienced the following problems/side effects: chronic myelomonocytic leukaemia, cytogenetic abnormality, . PREDNISONE dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE. Patient recovered.
CHRONIC MYELOMONOCYTIC LEUKAEMIA : Actos Side Effects Report #5670132-9
Health Professional from GERMANY reported ACTOS problem on Feb 28, 2008. Female patient, 70 years of age, was diagnosed with type 2 diabetes mellitus and was treated with ACTOS. After drug was administered, patient experienced the following problems/side effects: anaemia, chronic myelomonocytic leukaemia, dyspnoea, herpes zoster, impaired healing, necrosis, oedema peripheral, post herpetic neuralgia, . ACTOS dosage: 15 MG (15 MG, 1 - 2) PER ORAL, 15 MG (15 MG, 1 IN 1 D), PER ORAL. During the same period patient was treated with CORTISONE ACETATE, VERAPAMIL, CANDESARTAN CILEXETIL, HYDROCHLOROTHIAZIDE, ACETYLSALICYLIC ACID SRT, CALCIUM, VITAMIN D. Patient was hospitalized. Patient recovered.
CHRONIC MYELOMONOCYTIC LEUKAEMIA : Neulasta Side Effects Report #5519596-1
NEULASTA problem was reported by a Physician from on Oct 24, 2007. Female patient was treated with NEULASTA. After drug was administered, patient experienced the following problems/side effects: bone pain, chronic myelomonocytic leukaemia, infection, surgery, white blood cell count increased, . NEULASTA dosage: unknown. During the same period patient was treated with TAXOTERE, FLUOROURACIL, CYCLOPHOSPHAMIDE, EPIRUBICIN. Patient was hospitalized. Patient recovered.
CHRONIC MYELOMONOCYTIC LEUKAEMIA : Fludara Side Effects Report #5395574-0
Physician from UNITED STATES reported FLUDARA problem on July 10, 2007. Male patient, 64 years of age, was diagnosed with b-cell lymphoma and was treated with FLUDARA. After drug was administered, patient experienced the following problems/side effects: acute myeloid leukaemia, chronic myelomonocytic leukaemia, . FLUDARA dosage: 25 MG/M2, CYCLE X 5D. During the same period patient was treated with RITUXAN. Patient died.
CHRONIC MYELOMONOCYTIC LEUKAEMIA : Fludara Side Effects Report #5395574-0
FLUDARA problem was reported by a Physician from UNITED STATES on July 10, 2007. Male patient, 64 years of age, was diagnosed with b-cell lymphoma and was treated with FLUDARA. After drug was administered, patient experienced the following problems/side effects: acute myeloid leukaemia, chronic myelomonocytic leukaemia, . FLUDARA dosage: 25 MG/M2, CYCLE X 5D. During the same period patient was treated with RITUXAN. Patient died.